Kissei Pharmaceutical Co., Ltd. (4547.T)
JPY 3775.0
(-1.82%)
JPY 3775.0
(-1.82%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 37.34 Billion JPY | 6.33% |
| 2022 | 32.37 Billion JPY | 3.64% |
| 2021 | 31.23 Billion JPY | -4.54% |
| 2020 | 32.72 Billion JPY | -6.25% |
| 2019 | 34.9 Billion JPY | -23.4% |
| 2018 | 45.56 Billion JPY | -5.31% |
| 2017 | 48.12 Billion JPY | 3.19% |
| 2016 | 46.63 Billion JPY | -2.27% |
| 2015 | 47.71 Billion JPY | 3.63% |
| 2014 | 46.04 Billion JPY | -2.48% |
| 2013 | 47.21 Billion JPY | 14.2% |
| 2012 | 41.34 Billion JPY | -1.01% |
| 2011 | 41.77 Billion JPY | -0.3% |
| 2010 | 41.89 Billion JPY | 3.65% |
| 2009 | 40.41 Billion JPY | -0.97% |
| 2008 | 40.81 Billion JPY | 5.52% |
| 2007 | 38.67 Billion JPY | 6.86% |
| 2006 | 36.19 Billion JPY | 1.32% |
| 2005 | 35.72 Billion JPY | -4.5% |
| 2004 | 37.4 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 10.51 Billion JPY | -3.35% |
| 2024 Q1 | 10.88 Billion JPY | 23.99% |
| 2023 Q2 | 8.71 Billion JPY | -9.03% |
| 2023 Q1 | 9.58 Billion JPY | 37.12% |
| 2023 FY | 34.42 Billion JPY | 6.33% |
| 2023 Q3 | 10.26 Billion JPY | 17.73% |
| 2023 Q4 | 8.77 Billion JPY | -14.5% |
| 2022 Q1 | 8.15 Billion JPY | 14.32% |
| 2022 FY | 32.37 Billion JPY | 3.64% |
| 2022 Q2 | 8.03 Billion JPY | -1.42% |
| 2022 Q3 | 9.2 Billion JPY | 14.54% |
| 2022 Q4 | 6.98 Billion JPY | -24.05% |
| 2021 Q2 | 7.59 Billion JPY | -3.41% |
| 2021 Q3 | 8.64 Billion JPY | 13.78% |
| 2021 FY | 31.23 Billion JPY | -4.54% |
| 2021 Q4 | 7.12 Billion JPY | -17.54% |
| 2021 Q1 | 7.86 Billion JPY | 9.17% |
| 2020 Q1 | 8.25 Billion JPY | 16.23% |
| 2020 Q3 | 9.42 Billion JPY | 20.2% |
| 2020 FY | 32.72 Billion JPY | -6.25% |
| 2020 Q4 | 7.2 Billion JPY | -23.52% |
| 2020 Q2 | 7.83 Billion JPY | -5.1% |
| 2019 Q1 | 10.04 Billion JPY | -4.14% |
| 2019 Q4 | 7.1 Billion JPY | -21.92% |
| 2019 Q3 | 9.1 Billion JPY | 5.18% |
| 2019 FY | 34.9 Billion JPY | -23.4% |
| 2019 Q2 | 8.65 Billion JPY | -13.86% |
| 2018 FY | 45.56 Billion JPY | -5.31% |
| 2018 Q3 | 12.92 Billion JPY | 20.83% |
| 2018 Q4 | 10.47 Billion JPY | -18.95% |
| 2018 Q1 | 11.45 Billion JPY | 7.25% |
| 2018 Q2 | 10.7 Billion JPY | -6.62% |
| 2017 FY | 48.12 Billion JPY | 3.19% |
| 2017 Q4 | 10.68 Billion JPY | -18.91% |
| 2017 Q3 | 13.17 Billion JPY | 12.97% |
| 2017 Q2 | 11.66 Billion JPY | -7.41% |
| 2017 Q1 | 12.59 Billion JPY | 17.61% |
| 2016 FY | 46.63 Billion JPY | -2.27% |
| 2016 Q1 | 12.33 Billion JPY | 12.6% |
| 2016 Q2 | 10.91 Billion JPY | -11.49% |
| 2016 Q3 | 12.67 Billion JPY | 16.14% |
| 2016 Q4 | 10.71 Billion JPY | -15.5% |
| 2015 Q1 | 11.56 Billion JPY | 3.87% |
| 2015 Q3 | 13.93 Billion JPY | 23.7% |
| 2015 Q2 | 11.26 Billion JPY | -2.56% |
| 2015 Q4 | 10.95 Billion JPY | -21.42% |
| 2015 FY | 47.71 Billion JPY | 3.63% |
| 2014 Q1 | 10.68 Billion JPY | 2.59% |
| 2014 FY | 46.04 Billion JPY | -2.48% |
| 2014 Q4 | 11.13 Billion JPY | -6.85% |
| 2014 Q3 | 11.95 Billion JPY | -2.71% |
| 2014 Q2 | 12.28 Billion JPY | 15.0% |
| 2013 Q4 | 10.41 Billion JPY | -31.6% |
| 2013 FY | 47.21 Billion JPY | 14.2% |
| 2013 Q1 | 10.98 Billion JPY | 12.51% |
| 2013 Q2 | 10.59 Billion JPY | -3.54% |
| 2013 Q3 | 15.22 Billion JPY | 43.6% |
| 2012 Q3 | 11.44 Billion JPY | 11.7% |
| 2012 FY | 41.34 Billion JPY | -1.01% |
| 2012 Q2 | 10.24 Billion JPY | 3.45% |
| 2012 Q1 | 9.9 Billion JPY | -0.27% |
| 2012 Q4 | 9.76 Billion JPY | -14.63% |
| 2011 Q1 | 10.07 Billion JPY | 4.52% |
| 2011 FY | 41.77 Billion JPY | -0.3% |
| 2011 Q2 | 10.55 Billion JPY | 4.74% |
| 2011 Q3 | 11.2 Billion JPY | 6.19% |
| 2011 Q4 | 9.92 Billion JPY | -11.44% |
| 2010 Q4 | 9.64 Billion JPY | -12.12% |
| 2010 Q1 | 11.08 Billion JPY | 20.5% |
| 2010 FY | 41.89 Billion JPY | 3.65% |
| 2010 Q2 | 10.2 Billion JPY | -7.93% |
| 2010 Q3 | 10.97 Billion JPY | 7.56% |
| 2009 Q2 | 10.36 Billion JPY | 1.74% |
| 2009 Q4 | 9.19 Billion JPY | -13.8% |
| 2009 Q3 | 10.66 Billion JPY | 2.89% |
| 2009 Q1 | 10.19 Billion JPY | -3.4% |
| 2009 FY | 40.41 Billion JPY | -0.97% |
| 2008 Q2 | 9.48 Billion JPY | 0.0% |
| 2008 FY | 40.81 Billion JPY | 5.52% |
| 2008 Q3 | 10.65 Billion JPY | 12.3% |
| 2008 Q4 | 10.54 Billion JPY | -1.0% |
| 2007 FY | 38.67 Billion JPY | 6.86% |
| 2006 FY | 36.19 Billion JPY | 1.32% |
| 2005 FY | 35.72 Billion JPY | -4.5% |
| 2004 FY | 37.4 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | 23.406% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 98.291% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 80.136% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 89.883% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -954.578% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 61.511% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | 2.305% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 93.632% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -522.558% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 52.716% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | 28.287% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -176.252% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -382.567% |
| Tsumura & Co. | 68.81 Billion JPY | 45.739% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -50.617% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 54.117% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -126.104% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | 25.588% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | 27.352% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -3360.704% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -279.52% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -746.54% |
| MedRx Co., Ltd | 26 Million JPY | -143519.231% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -365.267% |
| Solasia Pharma K.K. | 337 Million JPY | -10980.415% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 5108307.934% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -21.771% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 31.256% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -98832.281% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 66.95% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -462.398% |